Skip to content

TESS Shoulder Arthroplasty Data Collection

A Prospective, Multicentre Study Evaluating the Clinical Performance of the T.E.S.S Anatomic and Reverse Shoulder Prostheses

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00751673
Enrollment
600
Registered
2008-09-12
Start date
2006-01-31
Completion date
2019-10-31
Last updated
2019-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthritis

Brief summary

This observational study intends to collect efficacy and safety data on TESS shoulder system

Detailed description

The T.E.S.S.® shoulder system has been developed to provide a complete solution for all the indications for Shoulder Arthroplasty, Arthritis, Rotator Cuff Arthropathy, Proximal Humeral Fracture, minimising bone resection and restoring the natural anatomy of the patient.

Interventions

None listed

Sponsors

Biomet France SARL
CollaboratorINDUSTRY
Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* A pre-operative level of pain and function the same as for conventional joint replacement * A likelihood of obtaining relief of pain and improved function * Full skeletal maturity * Ability to follow instructions * Good general health for age * Willing to return for follow-up evaluations

Exclusion criteria

* Glenohumeral joint infection, osteomyelitis * Neuro-muscular complications * Inability to co-operate with and complete the study

Design outcomes

Primary

MeasureTime frameDescription
Change in Constant Murley Score6 months, 1 year, 2 year, 3 year, 4 year, 5 year, 7 year and 10 yearImprovement in this score will be collected at every follow-up visit.This is a 100-point score, containing 8 questions. Higher score indicate a better outcome.
Change in Oxford Score6 months, 1 year, 2 year, 3 year, 4 year, 5 year, 7 year and 10 yearImprovement in this score will be collected at every follow-up visit.This is a 60-point score, containing 12 questions. Higher score indicate a better outcome.

Secondary

MeasureTime frameDescription
ComplicationsAny timeGeneral and shoulder specific complicatons are collected any time.
Patient Satisfaction6 months, 1 year, 2 year, 3 year, 4 year, 5 year, 7 year and 10 yearBinary question.

Countries

Belgium, France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026